Correctable complications of neoplastic disease. I. Hypercalcemia
DeConti, R.C.
Connecticut Medicine 35(4): 275-276
1971
ISSN/ISBN: 0010-6178 PMID: 5550910 Document Number: 43165
Document emailed within 1 workday
Related Documents
Muggia, F.M.; Heinemann, H.O. 1970: Hypercalcemia associated with neoplastic disease Annals of Internal Medicine 73(2): 281-290Schmidt-Habelmann, P.; Mayr, N.; Sebening, F. 1984: Surgically correctable complications of myocardial infarct Schweizerische Medizinische Wochenschrift 114(13): 426-430
McMullan, M.H.; Kilgore, T.L. 1975: Surgically correctable complications of myocardial infarction Journal of the Mississippi State Medical Association 16(9): 288-290
Frenning, D.H. 1979: Hypercalcemia in neoplastic diseases Minnesota Medicine 62(7): 541-543
MacKenzie, K.S.; Hill, A.B.; Blundell, P.E. 1999: Surgically correctable hypertension mistaken for Takayasu's disease: a case report Canadian Journal of Surgery. Journal Canadien de Chirurgie 42(6): 462-465
Dosios, T.J.; Magovern, G.J.; Liebler, G.A.; Park, S.B.; Cushing, W.J. 1977: Assessment of the surgical management of coronary atherosclerosis coexisting with other surgically correctable heart disease Pennsylvania Medicine 80(11): 32-35
Vezyraki, P.; Vlachaki, A.; Baltogiannis, D.; Batistatou, A.; Tsampalas, S.; V Simos, Y.; Kaltsas, A.; Pappas, P.; Dounousi, E.; Ragos, V.; Tsiambas, E.; Peschos, D. 2019: Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities Journal of BUON: Official Journal of the Balkan Union of Oncology 24(5): 2107-2113
Terzolo, M.; Daffara, F.; Reimondo, G.; Allasino, B.; Ventura, M.; Angeli, A. 2003: The neoplastic complications of acromegaly Journal of Endocrinological Investigation 26(8 Suppl): 32-34
Ambrózy, G.; Lengyel, Z.; Vatai, M.; Eckhardt, S. 1976: Evaluation of lymphography in neurologic complications of neoplastic diseases Archiv für Geschwulstforschung 46(8): 667-675
De la Piedra, C.; Rapado, A.; Esbrit, P. 1985: Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia Revista Clinica Espanola 177(7): 310-313
Van Steensel-Moll, H.A.; Drop, S.L. 1986: Hypercalcemia in childhood. a boy with asymptomatic hypocalciuric hypercalcemia Tijdschrift Voor Kindergeneeskunde 54(5): 147-150
Eisinger, J.; D'Omezon, Y.; Recordier, A.M. 1973: Mithramycin in the treatment of hypercalcemia and Paget's disease Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(6): 457-460
Migueres, J.; Jover, A.; Krempf, M. 1975: Note on the complications of pleural needle biopsy: neoplastic seeding of the wall (apropos of 300 effusions and 440 puncture biopsies) Le Poumon et le Coeur 31(6): 347-349
1984: Absence of parathyroid hormone messenger RNA in malignant disease with hypercalcemia New England Journal of Medicine 310(5): 323-324
McKee, R.L.; Caulfield, M.P. 1989: Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy Peptide Research 2(2): 161-166
Kaplan, A.; Gyure, W.L. 1972: Mercury pollution from the laboratory: a correctable problem Clinical Chemistry 18(6): 593
Dumez, Y. 1993: Obstetrical management of surgically correctable fetal malformations Pediatrie 48(2): 99-107
Schaefer, O.; Hildes, J.A. 1975: Neoplastic disease in Eskimos Canadian Medical Association Journal 113(6): 493-495
Schaefer, O.; Hildes, J.A. 1975: Neoplastic disease in Eskimos Canadian Medical Association Journal 113(6): 493-495
Mazanowska, O.; Klinger, M. 2005: Glomerulonephritis in neoplastic disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(110): 211-214